| 2024-05-29 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 40,000 0.0394% | $133.46 | $5.34M | +0.03% | |
| 2023-01-03 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 15,000 0.0153% | $118.85 | $1.78M | -12.88% | |
| 2022-01-24 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 15,000 0.0154% | $74.43 | $1.12M | +29.8% | |
| 2020-04-28 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 17,687 0.0192% | $99.39 | $1.76M | +5.43% | |
| 2020-03-11 | Sale | Biogen Inc. BIIB | director | 4,868 0.0028% | $295.22 | $1.44M | -5.64% | |
| 2018-06-11 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 10,000 0.011% | $98.44 | $984,420 | -9.93% | |
| 2015-03-10 | Sale | Biogen Inc. BIIB | director | 12,000 0.0029% | $234.75 | $2.82M | -26.64% | |
| 2014-12-26 | Verastem, Inc. VSTM | director | 5,000 0.0194% | $8.56 | $42,790 | -12.05% | ||
| 2014-01-02 | Sale | Biogen Inc. BIIB | director | 11,000 0.0046% | $279.28 | $3.07M | +13.96% | |
| 2013-06-03 | Sale | Biogen Inc. BIIB | director | 25,650 0.0111% | $233.26 | $5.98M | +21% | |
| 2013-03-22 | Sale | Biogen Inc. BIIB | director | 3,000 0.0013% | $176.88 | $530,640 | +32.74% | |
| 2012-09-04 | Sale | Biogen Inc. BIIB | director | 4,000 0.0017% | $145.90 | $583,600 | +17.23% | |
| 2012-06-04 | Sale | Biogen Inc. BIIB | director | 5,000 0.002% | $126.45 | $632,250 | +14.8% | |
| 2011-12-19 | Sale | Biogen Inc. BIIB | director | 5,000 0.0021% | $110.88 | $554,400 | +25.51% | |
| 2004-09-22 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 5,000 0.0075% | $26.52 | $132,578 | -6.78% |